Macrophages secrete fibronectin (Fn)' (1-3), bind Fn (3-5), and have been reported to migrate in response to Fn fragments (6). In addition, the interaction of human macrophages with Fn provides a second signal that leads to enhanced complement and Fc receptor-mediated phagocytosis by these cells (7)(8)(9)(10)(11)(12)(13)(14) . The structure ofthe Fn receptor, or receptors, responsible for both adherence to Fn and Fn-mediated phagocytosis enhancement in macrophages is not completely understood . Previous studies have demonstrated membrane proteins on monocytes or culture-derived macrophages that interact with the 110-kD cell-binding domain of Fn (15). These proteins exhibit electrophoretic mobility typical of the recently described Fn receptor, termed VLA-5, purified from placenta, fibroblasts, the MG63 osteosarcoma cell line, erythroblasts, and platelets (reviewed in references 16-18) . This receptor is a heterodimer consisting of an ti 150-kD a chain and a 130-kD a chain under nonreducing conditions (19). Identification and sequence analysis of cDNA clones for both chains from a placental cDNA library has placed this receptor in the integrin family (18,20), whose members function in cellular adhesion . The VLA antigens form a part of this family and are defined by having a common R chain that can noncovalently combine with at least six distinct a chains (21)(22)(23)(24). We have recently demonstrated by Northern blot analysis the presence of mRNA that hybridizes with probes for both the VLA-5 a and the common VLA (3 chain in monocytes, as well as in the monocyte-like cell lines HL-60, THP, and U937 (25). In addition, partial cDNA clones that we have isolated from an HL-60 library have shown identical restriction
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.